MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $229 | -42.0% | 6,350 | -40.2% | 0.02% | -59.5% |
Q1 2023 | $395 | -99.9% | 10,623 | +12.7% | 0.04% | -30.0% |
Q3 2022 | $658,000 | -2.7% | 9,423 | -6.4% | 0.06% | +5.3% |
Q2 2022 | $676,000 | -45.0% | 10,070 | +32.4% | 0.06% | -52.1% |
Q2 2021 | $1,229,000 | +196.9% | 7,607 | +303.3% | 0.12% | +164.4% |
Q4 2020 | $414,000 | -46.1% | 1,886 | -59.2% | 0.04% | -65.9% |
Q3 2020 | $768,000 | +161.2% | 4,627 | +22.5% | 0.13% | +473.9% |
Q3 2019 | $294,000 | +12.6% | 3,776 | +6.1% | 0.02% | +53.3% |
Q1 2019 | $261,000 | – | 3,558 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |